Watch and Wait or Initiate: Providing Timely Access to Novel Therapies for Chronic Lymphocytic Leukemia
hosted byPrime Education, LLCWatch and Wait or Initiate: Providing Timely Access to Novel Therapies for Chronic Lymphocytic Leukemia is organized by Prime Education, LLC.
Release Date: October 05, 2023
Expiration Date: October 04, 2024
Description:
The decision to watch and wait or begin treatment in chronic lymphocytic leukemia (CLL) is complex; yet while clinicians struggle to navigate the latest clinical evidence, optimal patient outcomes are foremost impeded by barriers to timely access to care.
Tune in for a deep dive into the latest clinical data for new and emerging therapies in CLL and evidenced-based strategies for timely risk evaluation and treatment initiation in federal, public, and government healthcare settings.
Learning Objectives:
• Describe barriers to timely access to hematologic malignancy care and apply interprofessional strategies for addressing factors impeding optimal care
• Assess the role of molecular, predictive, and prognostic factors in guiding treatment decisions for patients with hematologic malignancies
• Differentiate targeted agents and immunotherapies based on mechanism of action, new safety and efficacy data, and place in therapy
